Indian vaccines market could triple to $1.65bn by 2020: McKinsey
This article was originally published in Scrip
Executive Summary
India's "small and underpenetrated" vaccines market could potentially scale the $1.60 billion mark in value in 2020, growing at 20% year-on-year this year onwards, if backed by appropriate public market interventions and initiatives by the government and the private sector, according to a report by McKinsey & Company and the Organisation of Pharmaceutical producers of India (OPPI).